Review of medication adherence in children and adults with ADHD
- PMID:20107302
- DOI: 10.3810/pgm.2010.01.2112
Review of medication adherence in children and adults with ADHD
Abstract
Objective: To review the literature on the prevalence, potential causes, and consequences of medication nonadherence in adult attention-deficit/hyperactivity disorder (ADHD).
Background: Attention-deficit/hyperactivity disorder is a common, chronic, and impairing neuropsychiatric disorder, affecting 4.4% of the US adult population. Medications alleviate many aspects of the disorder, but associated difficulties with disorganization and planning can lead patients to have poor adherence and subsequent treatment failure. This review will examine the scope and consequences of medication nonadherence in children and adults with ADHD.
Methods: Comprehensive literature reviews via PubMed searches were conducted for continuity of medication and medication adherence (and related terms) in ADHD (and ADD). The studies were reviewed and classified regarding prevalence, measure of adherence or continuity, etiology, and consequences of medication nonadherence in childhood/adolescent and adult ADHD.
Results: Studies of pharmacy claims databases and treatment studies have shown that the prevalence of medication discontinuation or nonadherence is between 13.2% to 64%. More studies have focused on medication adherence in children/adolescents than in adult ADHD. Medication nonadherence is more prevalent in immediate-release versus extended-release psychostimulants in childhood/adolescent ADHD, but differences in the formulations have not been studied extensively in adults. Current studies have almost exclusively relied on patient reports. Possible etiologies of medication nonadherence have not been examined with formal rating instruments in adult ADHD. The long-term consequences of medication nonadherence, in terms of impairments, have not been examined.
Conclusions: Studies have documented that medication nonadherence is common in childhood/adolescent ADHD. Further prospective studies are necessary to document the scope of the problem in adult ADHD and to examine the potential benefits of utilizing extended-release medications in adult ADHD. Studies correlating the impact of medication nonadherence on symptoms and impairments in adult ADHD are needed. Future studies should consider utilizing technology to document medication nonadherence, such as MEMS caps.
Similar articles
- Attention-deficit-hyperactivity disorder: an update.Dopheide JA, Pliszka SR.Dopheide JA, et al.Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656.Pharmacotherapy. 2009.PMID:19476419Review.
- Improving psychostimulant adherence in children with ADHD.Charach A, Gajaria A.Charach A, et al.Expert Rev Neurother. 2008 Oct;8(10):1563-71. doi: 10.1586/14737175.8.10.1563.Expert Rev Neurother. 2008.PMID:18928348Review.
- Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.Christensen L, et al.Curr Med Res Opin. 2010 Apr;26(4):977-89. doi: 10.1185/03007991003673617.Curr Med Res Opin. 2010.PMID:20178404
- Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.Winterstein AG, et al.Ann Pharmacother. 2008 Jan;42(1):24-31. doi: 10.1345/aph.1K143. Epub 2007 Nov 27.Ann Pharmacother. 2008.PMID:18042808
- ADHD medication use, adherence, persistence and cost among Texas Medicaid children.Barner JC, Khoza S, Oladapo A.Barner JC, et al.Curr Med Res Opin. 2011;27 Suppl 2:13-22. doi: 10.1185/03007995.2011.603303.Curr Med Res Opin. 2011.PMID:21973228
Cited by
- Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine.Haedener M, Weinmann W, Eich D, Liebrenz M, Wuethrich T, Buadze A.Haedener M, et al.PLoS One. 2021 Mar 30;16(3):e0248747. doi: 10.1371/journal.pone.0248747. eCollection 2021.PLoS One. 2021.PMID:33784320Free PMC article.
- Insights from pre-treatment attrition & dropouts in an effectiveness trial of methylphenidate in children.Shah R, Padhy S, Kohli A, Sharma S.Shah R, et al.Indian J Med Res. 2020 Sep;152(3):316-319. doi: 10.4103/ijmr.IJMR_1498_18.Indian J Med Res. 2020.PMID:33107494Free PMC article.No abstract available.
- Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review.Dinu LM, Phattharakulnij N, Dommett EJ.Dinu LM, et al.J Neural Transm (Vienna). 2022 Apr;129(4):361-377. doi: 10.1007/s00702-022-02478-5. Epub 2022 Mar 14.J Neural Transm (Vienna). 2022.PMID:35286460Free PMC article.Review.
- Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: immediate and long-term effects using a blind randomized controlled trial.Ferrin M, Moreno-Granados JM, Salcedo-Marin MD, Ruiz-Veguilla M, Perez-Ayala V, Taylor E.Ferrin M, et al.Eur Child Adolesc Psychiatry. 2014 Aug;23(8):637-47. doi: 10.1007/s00787-013-0494-7. Epub 2013 Dec 1.Eur Child Adolesc Psychiatry. 2014.PMID:24292412Clinical Trial.
- Evaluation of the effectiveness of the FOCUS ADHD App in monitoring adults with attention-deficit/hyperactivity disorder.Carvalho LR, Haas LM, Zeni G, Victor MM, Techele SP, Marrone Castanho J, Meneghetti Coimbra I, de Freitas de Sousa A, Ceretta N, Garrudo A, Grevet EH, Rohde LA.Carvalho LR, et al.Eur Psychiatry. 2023 Jun 21;66(1):e53. doi: 10.1192/j.eurpsy.2023.2422.Eur Psychiatry. 2023.PMID:37341028Free PMC article.Clinical Trial.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous